Company Filing History:
Years Active: 2023
Title: Innovations of Xiaoli Lu in PD-L1 Inhibitory Compounds
Introduction
Xiaoli Lu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target PD-L1, a protein associated with various diseases. His innovative work has the potential to impact the treatment of conditions linked to this protein.
Latest Patents
Xiaoli Lu holds a patent for a compound having PD-L1 inhibitory activity. The patent details a preparation method and the use of this compound for the prevention and treatment of diseases associated with PD-L1. Specifically, the patent provides a compound of formula I, including its stereoisomers, racemates, and pharmaceutically acceptable salts. This innovation is crucial for developing drugs aimed at combating diseases related to PD-L1.
Career Highlights
Xiaoli Lu is currently employed at Shanghai Ennovabio Pharmaceuticals Co., Ltd. His work at this company focuses on advancing pharmaceutical research and development, particularly in the area of immunotherapy. His expertise and innovative approach have positioned him as a key figure in the pharmaceutical industry.
Collaborations
Xiaoli Lu collaborates with notable colleagues, including Lei Jiang and Jianwen Deng. These partnerships enhance the research and development efforts at Shanghai Ennovabio Pharmaceuticals Co., Ltd., fostering an environment of innovation and discovery.
Conclusion
Xiaoli Lu's contributions to the field of pharmaceuticals, particularly through his patent on PD-L1 inhibitory compounds, highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of diseases associated with PD-L1.